Acute intermittent porphyria in two patients on anticonvulsant therapy and with normal erythrocyte porphobilinogen deaminase activity.

1. Acute intermittent porphyria (AIP) is sometimes termed a 'pharmacogenetic' disease. patients with genetic deficiency of the enzyme porphobilinogen deaminase are liable to develop acute attacks of porphyria if exposed to a variety of drugs. 2. Two patients are reported who had no evidenc...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Herrick, A L, McColl, K E, Moore, M R, Brodie, M J, Adamson, A R, Goldberg, A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 1989
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1379729/
https://ncbi.nlm.nih.gov/pubmed/2497768
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items